2025-06-24
June 23, 2025 – London, UK – REDONE FOOTBALL INVESTMENT GROUP LTD today announced the official appointment of Thomas Bennett as the new Head of Asia-Pacific. In this role, he will oversee the strategic development and ecosystem expansion across the region. This appointment signals a major shift as REDONE transitions its Asia-Pacific operations into a new phase focused on Web3 sports, governed by a DAO (Decentralized Autonomous Organization) framework.
Headquartered in London, UK, REDONE FOOTBALL INVESTMENT GROUP LTD is committed to deeply integrating real-world sports passion with Web3 technology. Through its ecosystem token ROT, REDONE is building a new collaborative and value exchange system for fans, athletes, and developers worldwide.
As part of its new strategy, REDONE’s Asia-Pacific region will gradually evolve into a DAO-led structure, empowering users and communities to actively participate in governance and ecosystem development through decentralized mechanisms.
“Asia-Pacific is not only a growth market, but the future hub of global Web3 sports interaction,” said a spokesperson from REDONE’s London headquarters. “By appointing a regional head and implementing DAO-based governance, we aim to truly empower fans, athletes, and developers to co-create the next-generation decentralized sports platform.”
Key Highlights:
REDONE has already established strategic partnerships with professional football clubs, sports data providers, and foundational Web3 infrastructure companies. This governance transformation will grant the Asia-Pacific community greater autonomy, enabling collaborative contributions to product planning, partner integration, and incentive mechanisms.
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
MEXC Claims Dual Wins at BeInCrypto 100 Awards as Best Centralized Exchange and Best Exchange in LATAM
©copyright 2009-2020 Singapore Info Map